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Abstract
Background Common bile duct (CBD) stones are a
potentially life-threatening medical condition. Patients with
proven CBD stones should undergo stone extraction. The
aim of this study was to evaluate whether performing
endoscopic ultrasound (EUS) and endoscopic retrograde
cholangiopancreatography (ERCP) for symptomatic CBD
stones in a single session reduces complications related to
postponing treatment due to separate EUS and ERCP ses-
sions, and to assess the safety in both options.
Methods A total of 151 patients with EUS-proven CBD
stones, with subsequent ERCP, treated in our department
between January 2005 and December 2011 were included.
Complications related to the procedures or sedation and
complications due to the CBD stones when EUS and ERCP
were not performed in a single session were assessed and
compared to complications when the two procedures were
performed in one session.
Results In total, 149 patients of the 151 (98.7 %) had a
successful ERCP. Four (5 %) patients in the separate-ses-
sion group (B) had a major complication compared to none
in the single-session group (A) (p [ 0.05). Group B
received 14 % more midazolam during ERCP than group
A (p \ 0.05). No sedation-related complications were
noted in either group. Eleven of the 80 patients in group B
(13.8 %) experienced complications while waiting for
ERCP compared to none in group A (p = 0.001,
OR = 2.17, CI = 1.06–4.
Conclusions EUS and ERCP done in a single session
proved to be safe, with no increase in sedation- or proce-
dure-related complications. Postponing treatment for
symptomatic CBD stones exposes the patient to biliary
complications, especially cholangitis.
Keywords EUS  ERCP  CBD  Choledocholithiasis
The prevalence of cholelithiasis in Western countries ran-
ges between 10 and 20 % [1]. Among these patients,
common bile duct (CBD) stones are present in up to
15–20 % [2]. The natural history of CBD stones is not well
known, but they may lead to serious complications such as
severe abdominal pain, biliary pancreatitis, obstructive
jaundice, ascending cholangitis, and hepatic abscess for-
mation [3]. Therefore, patients with proven CBD stones
should undergo stone extraction, either by endoscopic
retrograde cholangiopancreatography (ERCP) or by intra-
operative bile duct examination during cholecystectomy
[3]. In order not to expose patients to unnecessary invasive
interventions, it is recommended that patients with a
moderate to high index of suspicion for CBD stones
undergo prior noninvasive evaluation of their CBD by
endoscopic ultrasound (EUS) or magnetic resonance
imaging (MRI) [4].
Performing EUS before ERCP can prevent two thirds of
unnecessary ERCPs [5]. A recent study showed that ERCP
for CBD stone extraction after a positive EUS for low- to
moderate-risk patients, performed during the same endo-
scopic session, is safe and efficacious compared to when
the sessions are performed separately [6].
The aim of our study was to evaluate whether per-
forming EUS and ERCP for symptomatic CBD stones in a
single session will reduce complications related to
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postponing treatment due to separate EUS and ERCP ses-
sions, and to assess the safety in both options.
Patients and methods
All EUS studies performed in our department from January
2005 to December 2011 were reviewed. Those reporting
CBD stones and followed by an ERCP were included and
reviewed. The following data were recorded: demograph-
ics, comorbidities, relevant medication history, time
elapsed between the EUS and ERCP (if separate sessions
were performed), complications related to the procedures
or sedation, complications due to the CBD stones when
EUS and ERCP were not performed in a single session,
gallbladder status, and the presence of a periampullary
diverticulum.
The EUS studies were performed with a Pentax linear
array echoendoscope (EG-3870UTK or EG-3830UTK),
and the ERCP studies were performed with Olympus TJF
160VR duodenoscopes. Patients who had consecutive
sessions of EUS and ERCP were transferred from the EUS
suite to the ERCP suite in the same endoscopy unit. All
procedures were done by experienced interventional
endoscopists.
Statistical analysis
Categorical data are presented as numbers and percentage
and continuous data as mean ± standard deviation. Dif-
ferences between nominal data were compared by v2. Risk
factors were calculated by the OR (odds ratio) and 95 % CI
(confidence interval). Continuous data were compared
using the t test. A p value \0.05 was considered statisti-
cally significant. All statistical analyses were performed
using SPSS v19 software (SPSS, Inc., Chicago, IL).
Results
A total of 151 patients with CBD stones confirmed by EUS
where included in the study. The patients were divided into
two groups (Table 1). Group A (71 patients, 43.7 % men)
underwent the EUS and ERCP in a single session and
group B (80 patients, 52.5 % men) had the two procedures
in separate sessions (p [ 0.05), with a median time from
EUS to ERCP of 7 days (range = 2–97). The mean age in
groups A and B was 58.2 ± 18.4 and 67.7 ± 15.7 years,
respectively (p = 0.001). No difference was noted between
the two groups regarding diabetes, hypertension, dyslipi-
demia, use of aspirin or cholesterol-lowering drugs, gall-
bladder status, presence of a periampullary diverticulum,
and CBD diameter (Table 1). Indications for EUS in all
patients are detailed in Fig. 1, with no differences found
between groups A and B.
ERCP characteristics are detailed in Table 2. In total,
149 patients of the 151 (98.7 %) had a successful ERCP.
Stones were removed from 126 of the 151 patients
(83.4 %): 88.7 % of group A and 78.8 % of group B
(p [ 0.05). All patients had a sphincterotomy performed,
and three patients needed the assistance of a precut pro-
cedure (1 in group A and 2 in group B). Seventy of the 71
patients (98.6 %) in group A and 73 of the 80 (91.2 %) in
group B had their stones removed with an extraction bal-
loon. One patient (1.4 %) in group A and 7 (8.8 %) in
group B had their stones extracted with a basket
(p [ 0.05). One patient in each group had a failed ERCP
and the stones had to be removed in surgery. Two patients
in group B needed a rendezvous procedure to complete the
ERCP and stone extraction. Three patients in group B
needed more than one ERCP for the complete extraction of
all CBD stones. Minor complications were present in 11
(15.7 %) and 13 (16.2 %) patients in groups A and B,
respectively (p [ 0.05) and included postsphincterotomy
bleeding that stopped spontaneously or with balloon tam-
ponade or mild pancreatitis with spontaneous resolution.
Four (5 %) patients in group B had a major complication.
One had a severe postsphincterotomy hemorrhage neces-
sitating admission, blood transfusions, and endoscopic
intervention. One patient had a perforation treated by sur-
gery and made a full recovery. Two patients died from
severe post-ERCP pancreatitis. No major complications
were noted in group A (p [ 0.05).
All patients were sedated with midazolam and fentanyl.
During EUS, patients in group A received 4.6 ± 1.4 mg
midazolam and 84 ± 19 lg fentanyl compared to patients
in group B who received 4.4 ± 1.4 mg midazolam and
81 ± 21 lg fentanyl (p = NS for both). During ERCP,
patients in group A received 5.7 ± 2 mg midazolam and
92 ± 24 lg fentanyl and patients in group B received
6.5 ± 2.1 mg midazolam and 97 ± 21 lg fentanyl






Men 31 (43.7 %) 42 (52.5 %) NS
Age (years) 58.2 ± 18.4 67.7 ± 15.7 \0.01
CBD (mm) 7.5 ± 2.5 7.7 ± 2.4 NS
Post cholecystectomy 15 (21.1 %) 22 (27.5 %) NS
Periampullary
diverticulum
15 (21.1 %) 22 (27.5 %) NS
Aspirin use 18 (25 %) 32 (40 %) NS
Cholesterol-lowering
drugs
22 (31 %) 34 (42 %) NS
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(p \ 0.02 for midazolam and p = NS for fentanyl). A
14 % increase in the midazolam dose for ERCP was
recorded in group B. No sedation-related complications
were noted in either group.
Complications that occurred between EUS and ERCP
are shown in Table 3. Eleven of the 80 patients in group B
(13.8 %) experienced complications while waiting for
ERCP compared to none in group A (p = 0.001,
OR = 2.17, CI = 1.06–4.4). Six patients experienced
ascending cholangitis, four had biliary colic and elevated
liver enzymes, and one had pancreatitis. Approximately
60 % of the complications occurred within 30 days of
EUS. All 11 patients were treated successfully with ERCP,
sphincterotomy, and stone extraction.
Discussion
In the present study we have demonstrated that performing
consecutive EUS and ERCP for symptomatic CBD stones
in a single session is feasible and safe, with no increase in
procedure- or sedation-related complications. Moreover,
our data reveal an increased risk of performing ERCP in a
separate session causing postponing treatment of these
patients. Delaying ERCP resulted in significant biliary
complications (including cholangitis and pancreatitis) in
14 % of patients.
CBD stones are a potentially life-threatening medical
condition. Prompt treatment is recommended and urgency
varies depending on the severity of the manifestation of
CBD stones [7]. In the last decade EUS has become the
procedure of choice for detecting CBD stones [8]. Its use
prevents about 60 % of unnecessary ERCPs in patients
with suspected CBD stones [5]. ERCP is reserved only for
therapeutic procedures [5] because of its invasive nature
and accompanying complications, especially when a
sphincterotomy is performed [9].
Previous studies have demonstrated the safety of per-
forming EUS and ERCP in a single session. These studies
included patients with a variety of pancreaticobiliary con-
ditions such as malignant tumors (pancreas, bile ducts, and
ampulla), benign biliary strictures, pancreatic cysts, and
Fig. 1 Indications for EUS
Table 2 ERCP characteristics
Group A (n = 71) B (n = 80) p value
Successful ERCP 70 (98.5 %) 79 (98.7 %) NS
[1 ERCP 0 3 (3.7 %) NS
Stone removal 63 (88.7 %) 63 (78.8 %) NS
Minor complications 11 (15.7 %) 13 (16.2 %) NS
Major complications 0 4 (5 %) NS
Table 3 Complications during waiting period
Group A (n = 71) B (n = 80)
Total 0 11 (14 %)*
Ascending cholangitis - 6/11 (55 %)
Biliary colic ? LFTs: - 4/11 (36 %)
Biliary pancreatitis - 1/11 (9 %)
OR 2.17, CI 1.06–4.4
* p = 0.001
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chronic pancreatitis [10]. They evaluated the safety and
cost-effectiveness in terms of procedural and anesthetic
complications and found that performing the two proce-
dures in one session is safe. Ross et al. [12] evaluated 114
patients who underwent EUS and ERCP in a single session
but they did not compare it with performing the procedures
in separate sessions. Moreover, 70 % of their patients had a
malignancy while only 1.7 % had CBD stones. Studies [10,
11, 13] that have compared single versus separate sessions
of EUS and ERCP were based on small samples (35–85
patients), with a minority of patients having CBD stones.
None of these studies evaluated the consequence of mor-
bidity due to postponing the treatment for symptomatic
CBD. Our study included 151 patients in two groups, one
had single session and the other had separate sessions, and
all of whom had CBD stones. We demonstrated an OR of
2.17 for developing CBD stone-related complications when
postponing treatment with a separate ERCP session. The
ERCP success rate was similar in both groups (98.5 vs.
98.7 %) with similar success in stone extraction (group A,
88.7 %; group B, 78.8 %, p [ 0.05). Fewer stones were
extracted from the CBD in the separate-session group,
although the difference was not statistically significant.
This may mean that there was spontaneous stone passage.
The sensitivity of cholangiography for CBD stones during
ERCP is imperfect, ranging between 89 and 93 % [14].
False-negative ERCP usually occurs when small stones are
present in a dilated duct [15]. The mean waiting period
between EUS and ERCP in our study was 7 days
(range = 2–97), similar to that reported by Aslanian et al.
[13]. Group B was older than group A (58.2 ± 18.4 vs.
67.7 ± 15.7 years, p \ 0.05); revising the charts showed
no consideration bias except for convenience of the
admitting and gastroenterology departments. No difference
was noted in our study between groups A and B in pro-
cedural complication rates, which were similar to the rates
reported in other studies [5, 12]. As in other studies, no
sedation-related complications were noted. The overall
sedation doses of midazolam and fentanyl were similar to
those given in other studies [10, 13]. Patients in group B
received more midazolam during ERCP than patients in
group A (6.5 ± 2.1 vs. 5.7 ± 2 mg, p \ 0.05); the patients
in group A were still partly sedated from the EUS per-
formed before ERCP.
One might argue that we could have used more MRCP
and less EUS for the detection of CBD stones. As men-
tioned before, EUS and MRCP are considered equal in
terms of CBD stone detection [4]. In our study, we chose to
investigate patients who underwent EUS and not MRCP for
the following reasons: (1) in our country EUS is more
available and less costly than MRCP ($375 compared to
$551, respectively). (2) As described previously in several
studies, EUS is more accurate than MRCP for the detection
of small CBD stones [16–18]. (3) Our aim was to provide a
comprehensive one-step approach for patients with sus-
pected CBD stones. Performing EUS for the detection of
such stones allows us to continue directly with treatment
during the same session.
In conclusion, to our knowledge, our study is the first
one to compare a large number of patients with an exclu-
sive diagnosis of CBD stones who underwent single versus
separate sessions of EUS and ERCP. We have demon-
strated that it is safe to perform EUS and ERCP in a single
session with no increase in sedation- or procedure-related
complications. Postponing treatment for symptomatic CBD
stones exposes the patient to biliary complications, espe-
cially cholangitis. Our data support the notion of estab-
lishing an integrated gastroenterology unit that can manage
CBD stones by a combined approach.
Disclosures Fabiana Benjaminov, Assaf Stein, George Lichtman,
Itamar Pomeranz, and Fred M. Konikoff have no conflicts of interest
or financial ties to disclose.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Shaffer EA (2006) Gallstone disease: epidemiology of gallblad-
der stone disease. Best Pract Res Clin Gastroenterol 20:981–996
2. Collins C, Maguire D, Ireland A et al (2004) A prospective study
of common bile duct calculi in patients undergoing laparoscopic
cholecystectomy: natural history of choledocholithiasis revisited.
Ann Surg 239:28–33
3. (1993) National institutes of health consensus development
conference statement on gallstones and laparoscopic cholecys-
tectomy. Am J Surg 165:390–398
4. Williams EJ, Green J, Beckingham I et al (2008) Guidelines on
the management of common bile duct stones (CBDS). Gut
57:1004–1021
5. Petrov MS, Savides TJ (2009) Systematic review of endoscopic
ultrasonography versus endoscopic retrograde cholangiopancre-
atography for suspected choledocholithiasis. BJS 96:967–974
6. Fabbri C, Polifemo AM, Luigiamo C et al (2009) Single session
versus separate session endoscopic ultrasonography plus endo-
scopic retrograde cholangiography in patients with low to mod-
erate risk for choledocholithiasis. J Gastroenterol Hepatol
24:1107–1112
7. ASGE Standards of Practice Committee, Maple JT, Ikenberry
SO, Anderson MA, Appalaneni V, Decker GA, Early D, Evans
JA, Fanelli RD, Fisher D, Fisher L, Fukami N, Hwang JH, Jain R,
Jue T, Khan K, Krinsky ML, Malpas P, Ben-Menachem T, Sharaf
RN, Dominitz JA (2011) The role of endoscopy in the manage-
ment of choledocholithiasis. Gastrointest Endosc 74(4):731–743
8. Godfrey EM, Rushbrook SM, Carroll NR (2010) Endoscopic
ultrasound: a review of current diagnostic and therapeutic
applications. Postgrad Med J 86(1019):5700
9. Freeman ML (2002) Adverse events and success outcome of
ERCP. Gastrointest Endosc 56(6 Suppl):S273–S282
2120 Surg Endosc (2013) 27:2117–2121
123
10. Ascunce G, Ribeiro A, Rocha-Lima C et al (2010) Single-session
endoscopic ultrasonography and endoscopic retrograde cholan-
giopancreatography for evaluation of pancreaticobiliary disor-
ders. Surg Endosc 24:1447–1450
11. Vila JJ, Kutz M, Goni S et al (2011) Endoscopic and anesthetic
feasibility of EUS and ERCP combined in a single session versus
two different sessions. World J Gastrointest Endosc 3(3):57–61
12. Ross WA, Wasan SM, Evans DB et al (2008) Combined EUS
with FNA and ERCP for the evaluation of patients with
obstructive jaundice from presumed pancreatic malignancy.
Gastrointest Endosc 3:461–466
13. Aslanian HR, Estrada JD, Rossi F et al (2011) Endoscopic
ultrasound and endoscopic retrograde cholangiopancreatography
for obstructing pancreatic head mass. Combined or separate
procedures? J Clin Gastroenterol 45(8):711–713
14. Prat F, Amouyal G, Amouyal P et al (1999) Prospective con-
trolled study of endoscopic ultrasonography and endoscopic
retrograde cholangiopancreatography in patients with suspected
CBD lithiasis. Lancet 347:75–79
15. Tseng LJ, Jao YT, Mo LR et al (2001) Over-the-wire US catheter
probe as an adjunct to ERCP in the detection of choledocholi-
thiasis. Gastrointest Endosc 54:720–723
16. Aube´ C, Delorme B, Yzet T et al (2005) MR cholangiopancre-
atography versus endoscopic ultrasonography in suspected com-
mon bile duct lithiasis: a comparative prospective study. AJR Am
J Roentgenol 184:55–62
17. De Ledinghen V, Lecesne R, Raymond JM et al (1999) Diagnosis
of choledocholithiasis: EUS or magnetic resonance cholangiog-
raphy? A prospective controlled study. Gastrointest Endosc
49:26–31
18. Kondo S, Isayama H, Akahane M (2005) Detection of common
bile duct stones: Comparison between endoscopic ultrasound,
magnetic resonance cholangiography and helical-computed-
tomographic cholangiography. Eur J Radiol 54:271–275
Surg Endosc (2013) 27:2117–2121 2121
123
